163 related articles for article (PubMed ID: 11460306)
1. Development of immunoadjuvants for immunotherapy of cancer.
Azuma I; Seya T
Int Immunopharmacol; 2001 Jul; 1(7):1249-59. PubMed ID: 11460306
[TBL] [Abstract][Full Text] [Related]
2. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.
Ishii K; Kurita-Taniguchi M; Aoki M; Kimura T; Kashiwazaki Y; Matsumoto M; Seya T
Immunol Lett; 2005 May; 98(2):280-90. PubMed ID: 15860229
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH
Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages.
Begum NA; Ishii K; Kurita-Taniguchi M; Tanabe M; Kobayashi M; Moriwaki Y; Matsumoto M; Fukumori Y; Azuma I; Toyoshima K; Seya T
Infect Immun; 2004 Feb; 72(2):937-48. PubMed ID: 14742539
[TBL] [Abstract][Full Text] [Related]
5. Two receptor theory in innate immune activation: studies on the receptors for bacillus Culmet Guillen-cell wall skeleton.
Seya T; Matsumoto M; Tsuji S; Begum NA; Nomura M; Azuma I; Hayashi A; Toyoshima K
Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 1():S13-21. PubMed ID: 11603865
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical and immunological properties of the fractions of tubercle bacilli].
Azuma I
Kekkaku; 1998 Feb; 73(2):65-70. PubMed ID: 9545698
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of ovarian cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: effect of lymphadenectomy.
Hayashi A; Nishida Y; Yoshii S; Kim SY; Uda H; Hamasaki T
Cancer Sci; 2009 Oct; 100(10):1991-5. PubMed ID: 19656158
[TBL] [Abstract][Full Text] [Related]
8. Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology.
Masuda H; Nakamura T; Noma Y; Harashima H
Mol Pharm; 2018 Dec; 15(12):5762-5771. PubMed ID: 30380885
[TBL] [Abstract][Full Text] [Related]
9. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors.
Tsuji S; Matsumoto M; Takeuchi O; Akira S; Azuma I; Hayashi A; Toyoshima K; Seya T
Infect Immun; 2000 Dec; 68(12):6883-90. PubMed ID: 11083809
[TBL] [Abstract][Full Text] [Related]
10. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
Nishida S; Tsuboi A; Tanemura A; Ito T; Nakajima H; Shirakata T; Morimoto S; Fujiki F; Hosen N; Oji Y; Kumanogoh A; Kawase I; Oka Y; Azuma I; Morita S; Sugiyama H
Medicine (Baltimore); 2019 Aug; 98(33):e16771. PubMed ID: 31415377
[TBL] [Abstract][Full Text] [Related]
11. Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton.
Matsumoto M; Seya T; Kikkawa S; Tsuji S; Shida K; Nomura M; Kurita-Taniguchi M; Ohigashi H; Yokouchi H; Takami K; Hayashi A; Azuma I; Masaoka T; Kodama K; Toyoshima K; Higashiyama M
Int Immunopharmacol; 2001 Aug; 1(8):1559-69. PubMed ID: 11515819
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
[TBL] [Abstract][Full Text] [Related]
14. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y
Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant engineering for cancer immunotherapy: Development of a synthetic TLR2 ligand with increased cell adhesion.
Akazawa T; Inoue N; Shime H; Kodama K; Matsumoto M; Seya T
Cancer Sci; 2010 Jul; 101(7):1596-603. PubMed ID: 20507323
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor activity of bacterial fractions and related synthetic compounds].
Azuma I; Yamamura Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2691-9. PubMed ID: 6508322
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
Yamamura Y; Yoshizaki K; Azuma I; Yagura T; Watanabe T
Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
[TBL] [Abstract][Full Text] [Related]
18. Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine.
Koike Y; Yoo YC; Mitobe M; Oka T; Okuma K; Tono-oka S; Azuma I
Vaccine; 1998 Dec; 16(20):1982-9. PubMed ID: 9796054
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS) for cervical cancer.
Shibata T; Takata E; Sakamoto J; Shioya A; Yamada S; Takakura M; Sasagawa T
Medicine (Baltimore); 2022 Dec; 101(52):e32481. PubMed ID: 36595982
[TBL] [Abstract][Full Text] [Related]
20. Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy.
Yuk JM; Shin DM; Song KS; Lim K; Kim KH; Lee SH; Kim JM; Lee JS; Paik TH; Kim JS; Jo EK
Autophagy; 2010 Jan; 6(1):46-60. PubMed ID: 19901560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
